MedCity News October 16, 2020
Elise Reuter

The Bay Area hearing device-maker planned to raise $141.3 million in an upsized IPO. Its stock started trading on Nasdaq under the ticker “EAR.”

A Bay Area startup building tiny, “invisible” hearing aids went public on Friday. Eargo began trading on Nasdaq under the ticker “EAR,” at $18 per share.

In total, the startup expects to sell 7.85 million shares of its stock, bringing in proceeds of more than $141.3 million. The upsized IPO fetched more than Eargo had initially planned, with an expected range of $15 to $16 per share, according to its most recent prospectus.

San Jose, Calif.-based Eargo makes small, rechargeable hearing aids that sit in the user’s ear canal, so others can’t see them. They sell...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Investments, Medical Devices, Technology, Trends
Spinoffs, sales and tuck-ins top medtech deal priorities: Moody’s
Bayer and ASPIVIX collaborate on women’s health device
STAT+: Medicare official says breakthrough device reimbursement rule coming in early summer
Brain-computer interface research reaches new frontiers
Opinion: STAT+: How AI can help satisfy FDA’s drug, device diversity requirements

Share This Article